218 related articles for article (PubMed ID: 36607269)
1. Protein Nanoparticle-Mediated Delivery of Recombinant Influenza Hemagglutinin Enhances Immunogenicity and Breadth of the Antibody Response.
Badten AJ; Ramirez A; Hernandez-Davies JE; Albin TJ; Jain A; Nakajima R; Felgner J; Davies DH; Wang SW
ACS Infect Dis; 2023 Feb; 9(2):239-252. PubMed ID: 36607269
[TBL] [Abstract][Full Text] [Related]
2. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
[TBL] [Abstract][Full Text] [Related]
3. Designed nanoparticles elicit cross-reactive antibody responses to conserved influenza virus hemagglutinin stem epitopes.
McCraw DM; Myers ML; Gulati NM; Prabhakaran M; Brand J; Andrews S; Gallagher JR; Maldonado-Puga S; Kim AJ; Torian U; Syeda H; Boyoglu-Barnum S; Kanekiyo M; McDermott AB; Harris AK
PLoS Pathog; 2023 Aug; 19(8):e1011514. PubMed ID: 37639457
[TBL] [Abstract][Full Text] [Related]
4. Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants.
Hernandez-Davies JE; Dollinger EP; Pone EJ; Felgner J; Liang L; Strohmeier S; Jan S; Albin TJ; Jain A; Nakajima R; Jasinskas A; Krammer F; Esser-Kahn A; Felgner PL; Nie Q; Davies DH
Sci Rep; 2022 Jun; 12(1):9198. PubMed ID: 35654904
[TBL] [Abstract][Full Text] [Related]
5. Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components.
Hernandez-Davies JE; Felgner J; Strohmeier S; Pone EJ; Jain A; Jan S; Nakajima R; Jasinskas A; Strahsburger E; Krammer F; Felgner PL; Davies DH
Front Immunol; 2021; 12():692151. PubMed ID: 34335601
[TBL] [Abstract][Full Text] [Related]
6. Combined Intranasal Nanoemulsion and RIG-I Activating RNA Adjuvants Enhance Mucosal, Humoral, and Cellular Immunity to Influenza Virus.
Wong PT; Goff PH; Sun RJ; Ruge MJ; Ermler ME; Sebring A; O'Konek JJ; Landers JJ; Janczak KW; Sun W; Baker JR
Mol Pharm; 2021 Feb; 18(2):679-698. PubMed ID: 32491861
[TBL] [Abstract][Full Text] [Related]
7. Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques.
Florek KR; Weinfurter JT; Jegaskanda S; Brewoo JN; Powell TD; Young GR; Das SC; Hatta M; Broman KW; Hungnes O; Dudman SG; Kawaoka Y; Kent SJ; Stinchcomb DT; Osorio JE; Friedrich TC
J Virol; 2014 Nov; 88(22):13418-28. PubMed ID: 25210172
[TBL] [Abstract][Full Text] [Related]
8. A single-shot adenoviral vaccine provides hemagglutinin stalk-mediated protection against heterosubtypic influenza challenge in mice.
Bliss CM; Freyn AW; Caniels TG; Leyva-Grado VH; Nachbagauer R; Sun W; Tan GS; Gillespie VL; McMahon M; Krammer F; Hill AVS; Palese P; Coughlan L
Mol Ther; 2022 May; 30(5):2024-2047. PubMed ID: 34999208
[TBL] [Abstract][Full Text] [Related]
9. Development of a Pan-H1 Influenza Vaccine.
Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
[TBL] [Abstract][Full Text] [Related]
10. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
[TBL] [Abstract][Full Text] [Related]
11. Greater Breadth of Vaccine-Induced Immunity in Females than Males Is Mediated by Increased Antibody Diversity in Germinal Center B Cells.
Ursin RL; Dhakal S; Liu H; Jayaraman S; Park HS; Powell HR; Sherer ML; Littlefield KE; Fink AL; Ma Z; Mueller AL; Chen AP; Seddu K; Woldetsadik YA; Gearhart PJ; Larman HB; Maul RW; Pekosz A; Klein SL
mBio; 2022 Aug; 13(4):e0183922. PubMed ID: 35856618
[TBL] [Abstract][Full Text] [Related]
12. mRNA vaccines encoding computationally optimized hemagglutinin elicit protective antibodies against future antigenically drifted H1N1 and H3N2 influenza viruses isolated between 2018-2020.
Allen JD; Ross TM
Front Immunol; 2024; 15():1334670. PubMed ID: 38533508
[TBL] [Abstract][Full Text] [Related]
13. Development of an mRNA vaccine against a panel of heterologous H1N1 seasonal influenza viruses using a consensus hemagglutinin sequence.
Ma N; Xia ZW; Zhang ZG; Nian XX; Li XD; Gong Z; Zhang GM; Le Y; Zhou R; Zhang JY; Yang XM
Emerg Microbes Infect; 2023 Dec; 12(1):2202278. PubMed ID: 37067355
[TBL] [Abstract][Full Text] [Related]
14. Induction of Cross-Reactive Hemagglutination Inhibiting Antibody and Polyfunctional CD4+ T-Cell Responses by a Recombinant Matrix-M-Adjuvanted Hemagglutinin Nanoparticle Influenza Vaccine.
Shinde V; Cai R; Plested J; Cho I; Fiske J; Pham X; Zhu M; Cloney-Clark S; Wang N; Zhou H; Zhou B; Patel N; Massare MJ; Fix A; Spindler M; Thomas DN; Smith G; Fries L; Glenn GM
Clin Infect Dis; 2021 Dec; 73(11):e4278-e4287. PubMed ID: 33146720
[TBL] [Abstract][Full Text] [Related]
15. Post-fusion influenza vaccine adjuvanted with SA-2 confers heterologous protection via Th1-polarized, non-neutralizing antibody responses.
Nishiyama A; Adachi Y; Tonouchi K; Moriyama S; Sun L; Aoki M; Asanuma H; Shirakura M; Fukushima A; Yamamoto T; Takahashi Y
Vaccine; 2023 Jul; 41(31):4525-4533. PubMed ID: 37330368
[TBL] [Abstract][Full Text] [Related]
16. Influenza immune imprinting synergizes PEI-HA/CpG nanoparticle vaccine protection against heterosubtypic infection in mice.
Dong C; Ma Y; Zhu W; Wang Y; Kim J; Wei L; Gill HS; Kang SM; Wang BZ
Vaccine; 2024 Jan; 42(2):111-119. PubMed ID: 38097456
[TBL] [Abstract][Full Text] [Related]
17. Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.
Broecker F; Zheng A; Suntronwong N; Sun W; Bailey MJ; Krammer F; Palese P
J Virol; 2019 Sep; 93(18):. PubMed ID: 31375573
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Immune Response towards Generation of Universal Anti-HA-Stalk Antibodies after Immunization of Broiler Hens with Triple H5N1/NA-HA-M1 VLPs.
Gromadzka B; Chraniuk M; Hovhannisyan L; Uranowska K; Szewczyk B; Narajczyk M; Panasiuk M
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458460
[TBL] [Abstract][Full Text] [Related]
19. Identification of Linear Peptide Immunogens with Verified Broad-spectrum Immunogenicity from the Conserved Regions within the Hemagglutinin Stem Domain of H1N1 Influenza Virus.
Li S; Qiao Y; Xu Y; Li P; Nie J; Zhao Q; Chai W; Shi Y; Kong W; Shan Y
Immunol Invest; 2022 Feb; 51(2):411-424. PubMed ID: 33078652
[TBL] [Abstract][Full Text] [Related]
20. Globular Head-Displayed Conserved Influenza H1 Hemagglutinin Stalk Epitopes Confer Protection against Heterologous H1N1 Virus.
Klausberger M; Tscheliessnig R; Neff S; Nachbagauer R; Wohlbold TJ; Wilde M; Palmberger D; Krammer F; Jungbauer A; Grabherr R
PLoS One; 2016; 11(4):e0153579. PubMed ID: 27088239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
